Received Mar 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z014409 | — |
No symptomatic/additional AE; Inbound call from nurse calling to report TE for PROQUAD that had an excursion on 20-JAN-2026. The caller reports that a dose was administered to patient on 2-MAR-2026.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-Mar-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), valid lot #Z014409, expiration date: 10-Mar-2027 (dose and route of administration was not reported) as prophylaxis, that had an excursion on 20-JAN-2026, the vaccine was reconstituted with sterile diluent solution for injection (Hollister-Stier STERILE DILUENT) (lot # and expiration date was not reported) (product storage error). No symptomatic/additional adverse event (AE) was reported.
MERCK STERILE DILUENT